Conceptio › Archive › HAL (France)
HAL (France)open access

Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study

Marcus A. Urey et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
cardiomyopathyquality-of-life
Quality of life, 0, Gastrointestinal manifestations, Vutrisiran, 1, Cardiomyopathy, Transthyretin amyloidosis
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 983906
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.